<root>
	<PMID Version="1">25486933</PMID>
	<Summary>
		1: Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, Walker AE,Goitre L, Delle Monache S, Retta SF, Shiu YT, Grossmann AH, Thomas KR, Donato AJ,Lesniewski LA, Whitehead KJ, Li DY. Strategy for identifying repurposed drugs forthe treatment of cerebral cavernous malformation. Circulation. 2015 Jan20;131(3):289-99. doi: 10.1161/CIRCULATIONAHA.114.010403. Epub 2014 Dec 8. PubMedPMID: 25486933; PubMed Central PMCID: PMC4356181.
	</Summary>
	<MeshHeadingList>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D016543">Central Nervous System Neoplasms</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002762">Cholecalciferol</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D004195">Disease Models, Animal</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D058492">Drug Repositioning</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D004354">Drug Screening Assays, Antitumor</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D042783">Endothelial Cells</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D016166">Free Radical Scavengers</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D020786">Hemangioma, Cavernous, Central Nervous System</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D018345">Mice, Knockout</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008822">Mice, Transgenic</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
	    </MeshHeading>
	</MeshHeadingList>
</root>
